Predictions
Ligand Pharmaceuticals
Start price
Target price
Perf. (%)
€104.85
03.06.20
03.06.20
-
24.07.20
24.07.20
-1.57%
24.07.20
24.07.20
Moderna Inc.
Start price
Target price
Perf. (%)
€54.99
03.06.20
03.06.20
€60.00
04.06.20
04.06.20
-4.40%
04.06.20
04.06.20
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Zoom Video Communications Inc
Start price
Target price
Perf. (%)
€187.50
03.06.20
03.06.20
-
08.06.20
08.06.20
-0.53%
08.06.20
08.06.20
Arena Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€61.50
02.06.20
02.06.20
-
31.07.20
31.07.20
-14.63%
31.07.20
31.07.20
Seaworld Entertainment
Start price
Target price
Perf. (%)
€15.80
02.06.20
02.06.20
€18.00
04.11.21
04.11.21
67.09%
04.02.21
04.02.21
Zoom Video Communications Inc
Start price
Target price
Perf. (%)
€189.50
02.06.20
02.06.20
-
04.11.21
04.11.21
26.57%
05.11.21
05.11.21
Chesapeake Energy Corp.
Start price
Target price
Perf. (%)
€11.71
02.06.20
02.06.20
€12.00
08.06.20
08.06.20
231.82%
08.06.20
08.06.20
Moderna Inc.
Start price
Target price
Perf. (%)
€56.79
02.06.20
02.06.20
€75.00
20.07.20
20.07.20
52.21%
20.07.20
20.07.20
Capable Management
Medium risks for its business
Small cyclical dependencies
Could be very worthwhile Investment >20% year
Tilray Inc
Start price
Target price
Perf. (%)
€9.05
01.06.20
01.06.20
€100.00
15.06.20
15.06.20
-20.78%
15.06.20
15.06.20
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Standard Investments for future growth
Very capable Management
Fannie Mae (Federal National Mortgage Association)
Start price
Target price
Perf. (%)
€1.88
01.06.20
01.06.20
€2.00
14.06.20
14.06.20
-7.38%
14.06.20
14.06.20
EBIT growth > 30% per year expected
Very differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Zynga Inc.
Start price
Target price
Perf. (%)
€8.62
01.06.20
01.06.20
€11.00
05.06.20
05.06.20
-9.20%
05.06.20
05.06.20
Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€111.95
01.06.20
01.06.20
-
05.07.20
05.07.20
-0.22%
05.07.20
05.07.20